ORY
Oryzon Genomics SA
European company
Right Arrow 1
Healthcare
Right Arrow 2
Biotechnology
Bid
-
Ask
-
Last Traded
-
Chg
-
-
XMAD
-
Updated: -
Research
News & analysis
Loading...
Times are shown in GMT+2, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
Company Profile
Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics.
Symbol
XMAD:ORY
ISIN
ES0167733015
Currency
EUR
Loading...
Loading Comparison
Latest ORY News